Sadashiva Pai: Breakthroughs in Ovarian Microenvironment for Infertility
Sadashiva Pai, Founder and CEO at Science Mission LLC, shared a post on LinkedIn:
“Activating dormant eggs to restore fertility
A research team has made a major breakthrough in treating premature ovarian insufficiency (POI). The team discovered that finerenone, a drug used to treat type 2 diabetes-related chronic kidney disease, can promote the development of follicles into mature eggs and form viable embryos in patients with POI. In contrast to traditional strategies focusing solely on direct follicle stimulation, this pioneering study is the first to focus on improving the ovarian microenvironment to treat infertility caused by POI.
A related clinical trial confirmed that the participants experienced significant improvement in follicle development. About half of the participants successfully produced mature eggs, several of which developed into viable embryos. The results confirmed that this ground-breaking approach can restore fertility for women affected by POI. The research findings were published in the prestigious scientific journal Science.
The research team adopted the ‘drug repurposing’ strategy to explore novel treatment for POI-related infertility using drugs that have been approved and backed by established clinical safety data.
the team established a systematic screening platform and selected finerenone, a non-steroidal antifibrotic drug from a library of over a thousand drugs approved by the US Food and Drug Administration (FDA). The team found that finerenone has potential clinical value in improving the ovarian microenvironment and facilitating the development of small dormant follicles.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 9, 2026, 10:38Applications for the 2027 ASRM CELL Cohort Are Now Open – ASRM
-
Apr 9, 2026, 09:57Marco Zaccaria: SEUD 2026 Opens With Broad Focus on Women’s Reproductive Disorders
-
Apr 9, 2026, 09:41Behind the Lab: Portia Manngo’s Role at RIRCA
-
Apr 9, 2026, 09:08Quinn Chou: Who Is Eligible to Participate in DARE-APS?
-
Apr 9, 2026, 08:59John Cush: Ro+ Vs Ro- No Difference in Live Births or Preterm Births in SLE Pregnancies
-
Apr 9, 2026, 08:50Christopher Robinson: Uterine Scar Dehiscence at Next Pregnancy According to Uterine Closure Technique
-
Apr 9, 2026, 07:40DIVINE Calculator Makes IVF Dosing Safer Without Reducing Effectiveness – RBMO
-
Apr 9, 2026, 06:24The Defective Embryo That Could Be Your Baby – Fertility Plus
-
Apr 8, 2026, 16:03Kazem Nouri: Honored to Join AGCES 2026 on AI in IVF Outcomes